-
1 Comment
Ina Research Inc is currently in a long term downtrend where the price is trading 3.2% below its 200 day moving average.
From a valuation standpoint, the stock is 99.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.7.
Ina Research Inc's total revenue sank by 1.9% to $517M since the same quarter in the previous year.
Its net income has increased by 128.2% to $5M since the same quarter in the previous year.
Based on the above factors, Ina Research Inc gets an overall score of 2/5.
| ISIN | JP3146300003 |
|---|---|
| CurrencyCode | JPY |
| Exchange | TSE |
| Industry | Life Sciences Tools & Services |
| Sector | Healthcare |
| Target Price | None |
|---|---|
| PE Ratio | 8.04 |
| Dividend Yield | 2.1% |
| Market Cap | 3B |
| Beta | 0.21 |
Ina Research Inc., a consulting company, provides non-clinical and clinical studies services primarily in Japan. It offers Toxicology, Safety Pharmacology, Drug Dependence, Drug Efficacy, and QT/QTc studies, as well as support services for a range of non-clinical toxicity studies for pharmaceutical development, from the screening stage to preparation for clinical trials. The company also provides safety assessment of chemicals and agrichemicals. In addition, it offers efficacy studies for central nervous system, circulatory system, osteology, ophthalmology, blood glucose, nephritis, renal failure, total parenteral nutrition, and others; and clinical trial services, including QT/QTc studies. Further, the company provides health food studies comprising non-clinical studies; analysis services, including clinical pathology, pathology, and metabolism and chemical analysis; translation services for various non-clinical studies ranging from Japanese to English and vice versa; and quality assurance services for various studies. Additionally, it offers environmental equipment, published papers, and seminars archives. The company was formerly known as Shinshu Non-Clinical Laboratory Center and changed its name to Ina Research Inc. in July 1989. Ina Research Inc. was founded in 1974 and is headquartered in Ina, Japan. As of July 13, 2022, Ina Research Inc. operates as a subsidiary of Shin Nippon Biomedical Laboratories, Ltd..
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 2176.TSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024
